Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acsinfecdis.0c00579 http://scihub22266oqcxt.onion/10.1021/acsinfecdis.0c00579 33319978!ä!33319978 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ACS+Infect+Dis 2021 ; 7 (6): 1303-1316 Nephropedia Template TP {{tp|p=33319978|t=2021. Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic |pdf=|usr=}}{{33319978}} gab.com Text Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic JO: ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33319978 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic has disrupted global healthcare and economic systems throughout 2020 with no clear end in sight. While the pandemic continues to have deleterious effects across the globe, mechanisms for disrupting disease transmission have relied on behavioral controls (e.g., social distancing, masks, and hygiene) as there are currently no vaccines approved for use and limited therapeutic options. As this pandemic has demonstrated our vulnerability to newly emerging viruses, there has been strong interest in utilizing proteomics approaches to identify targets for repurposed drugs as novel therapeutic candidates that could be fast-tracked for human use. Building on a previous discussion on the combination of proteomics technologies with clinical data for combating emerging viruses, we discuss how these technologies are being employed for COVID-19 and the current state of knowledge regarding repurposed drugs in these efforts. Twit Text FOAVip Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic ????ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33319978 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33319978 #FOAvip English Wikipedia <ref>{{Cite pmid|33319978}}</ref> Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic #MMPMID33319978 Schindell BG; Allardice M; Lockman S; Kindrachuk J ACS Infect Dis 2021[Jun]; 7 (6): 1303-1316 PMID33319978show ga The coronavirus disease 2019 (COVID-19) pandemic has disrupted global healthcare and economic systems throughout 2020 with no clear end in sight. While the pandemic continues to have deleterious effects across the globe, mechanisms for disrupting disease transmission have relied on behavioral controls (e.g., social distancing, masks, and hygiene) as there are currently no vaccines approved for use and limited therapeutic options. As this pandemic has demonstrated our vulnerability to newly emerging viruses, there has been strong interest in utilizing proteomics approaches to identify targets for repurposed drugs as novel therapeutic candidates that could be fast-tracked for human use. Building on a previous discussion on the combination of proteomics technologies with clinical data for combating emerging viruses, we discuss how these technologies are being employed for COVID-19 and the current state of knowledge regarding repurposed drugs in these efforts. |*COVID-19[MESH] |*Pharmaceutical Preparations[MESH] |Drug Repositioning[MESH] |Humans[MESH] |Pandemics[MESH] |Proteomics[MESH]Integrating Proteomics for Facilitating Drug Identification and Repurp(epmc).pdf DeepDyve Pubget Overpricing